These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1395760)

  • 1. The effects of flosequinan on hemodynamics and oxygen delivery in cor pulmonale.
    Elborn JS; Richardson G; Murphy P; MacMahon J
    Chest; 1992 Oct; 102(4):1155-60. PubMed ID: 1395760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.
    Gottlieb SS; Kukin ML; Penn J; Fisher ML; Cines M; Medina N; Yushak M; Taylor M; Packer M
    J Am Coll Cardiol; 1993 Oct; 22(4):963-7. PubMed ID: 8409070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative hemodynamic response to short-term treatment with flosequinan (BTS 49465), a new direct-acting vasodilator drug, in severe chronic congestive heart failure.
    Kessler PD; Packer M; Medina N; Yushak M
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):6-11. PubMed ID: 2459536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of flosequinan on resting and exercise haemodynamics in congestive heart failure.
    Thomas P; O'Gorman DJ; Sheridan DJ
    Br J Clin Pharmacol; 1993 Dec; 36(6):539-46. PubMed ID: 12959270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vasodilator therapy for chronic obstructive pulmonary disease and cor pulmonale. Treatment with nifedipine, nitroglycerin, and oxygen.
    Morley TF; Zappasodi SJ; Belli A; Giudice JC
    Chest; 1987 Jul; 92(1):71-6. PubMed ID: 3109814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flosequinan induces hemodynamic improvement in heart failure complicating acute myocardial infarction.
    Schneeweiss A; Marmor A; Wynne RD
    Herz; 1988 Aug; 13(4):259-62. PubMed ID: 3169679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of phentolamine in cor pulmonale.
    Gould L; DeMartino A; Gomprecht RF; Umali F; Michael A
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):153-7. PubMed ID: 4482026
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of flosequinan on submaximal exercise in patients with chronic cardiac failure.
    Elborn JS; Riley M; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1990 May; 29(5):519-24. PubMed ID: 2112405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E; Seoane M; Verdejo J
    Chest; 1984 Feb; 85(2):156-63. PubMed ID: 6692695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.
    Geggel RL; Dozor AJ; Fyler DC; Reid LM
    Am Rev Respir Dis; 1985 Apr; 131(4):531-6. PubMed ID: 3994148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and regional hemodynamic effects of flosequinan for congestive heart failure.
    Haas GJ; Binkley PF; Carpenter JA; Leier CV
    Am J Cardiol; 1989 Jun; 63(18):1354-9. PubMed ID: 2658526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Adnot S; Andrivet P; Piquet J; Brun-Buisson C; Rauss A; Bignon J; Lemaire F
    Am Rev Respir Dis; 1988 May; 137(5):1068-74. PubMed ID: 3143277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prolonged oxygen therapy on pulmonary hypertension and blood viscosity in patients with advanced cor pulmonale.
    Głuskowski J; Jedrzejewska-Makowska M; Hawryłkiewicz I; Vertun B; Zieliński J
    Respiration; 1983; 44(3):177-83. PubMed ID: 6857003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flosequinan does not affect systemic and regional vascular responses to simulated orthostatic stress in healthy volunteers.
    Duranteau J; Pussard E; Edouard A; Samii K; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1992 Sep; 34(3):207-14. PubMed ID: 1389945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved cardiac performance by salbutamol, a selective beta 2-agonist, in chronic cor pulmonale.
    Vik-Mo H; Halvorsen FJ; Thorsen E; Walde NH; Rosland GA
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):129-34. PubMed ID: 2435988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved haemodynamics but reduced arterial blood oxygenation, at rest and during exercise after long-term oral prazosin therapy in chronic cor pulmonale.
    Vik-Mo H; Walde N; Jentoft H; Halvorsen FJ
    Eur Heart J; 1985 Dec; 6(12):1047-53. PubMed ID: 3938395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and neurohormonal effects of flosequinan in patients with heart failure.
    Isnard R; Lechat P; Pousset F; Carayon A; Kalotka H; Chikr H; Salloum J; Thomas D; Komajda M
    Fundam Clin Pharmacol; 1997; 11(1):83-9. PubMed ID: 9182081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E; Seoane M; Verdejo J; Gomez A; Sandoval J; Barrios R; Martinez W
    Chest; 1985 May; 87(5):564-73. PubMed ID: 3987368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure.
    Markus H; Cowley AJ
    Eur J Clin Pharmacol; 1991; 40(6):535-8. PubMed ID: 1884731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.